Inhibikase stock rises as FDA lifts clinical hold on Parkinson’s study
Grandbrothers/iStock Editorial via Getty Images Inhibikase Therapeutics (NASDAQ:IKT) stock rose ~12% on Wednesday after the company ...
Read moreGrandbrothers/iStock Editorial via Getty Images Inhibikase Therapeutics (NASDAQ:IKT) stock rose ~12% on Wednesday after the company ...
Read moreBiocon in the filing disclosed that the observations were primarily related to “the need for improving ...
Read moreThe U.S. Food and Drug Administration (FDA) has authorized two newly updated COVID-19 booster shots: one ...
Read moreGrandbrothers The U.S. Food and Drug Administration (FDA) accepted to review Astellas Pharma's (OTCPK:ALPMF) (OTCPK:ALPMY) application ...
Read moreIt could be a historic moment for many people having “mild to moderate hearing impairment” as ...
Read moreA healthcare worker prepares a syringe with the Moderna COVID-19 vaccine at a pop-up vaccination site ...
Read moreThe axe has fallen for e-cigarette maker Juul. The FDA ordered the company to stop selling ...
Read moreCOVID-19 vaccines will become available for infants, toddlers and preschoolers in the United States for the ...
Read moreThe Food and Drug Administration authorized on Friday both the Moderna and Pfizer-BioNTech coronavirus vaccines for ...
Read moreWASHINGTON — The only Americans still not eligible for coronavirus vaccines — babies, toddlers and preschoolers ...
Read more Copyright © 2022 - The Optic News.
The Optic News is not responsible for the content of external sites.